Xinmai Medical: Net profit expected to grow by 12.19% year-on-year in 2025, with a proposed dividend of 10 yuan per 10 shares.

MetaMuskRat · 2026-03-30T14:50:17+00:00

Xinmai Medical announces annual report, with 2025 operating revenue of 1.351 billion yuan, a year-on-year increase of 11.96%; net profit attributable to shareholders of 563 million yuan, a year-on-year increase of 12.19%. The company plans to distribute a cash dividend of 10 yuan for every 10 shares. R&D investment accounts for 9.37%, overseas sales have surged significantly, and there are a total of 759 patent applications.

MetaMuskRat

2026-03-30 14:50:17

Abstract generation in progress

People’s Finance Network, March 30—HeartPulse Medical (688016) disclosed its annual report on March 30. In 2025, the company achieved operating revenue of 1.351 billion yuan, up 11.96% year over year; net profit attributable to shareholders of 563 million yuan, up 12.19%; and basic earnings per share of 4.65 yuan. The company plans to distribute a cash dividend of 10 yuan for every 10 shares held (tax included). During the reporting period, the company’s total R&D investment was 127 million yuan, accounting for 9.37% of the company’s operating revenue for the same period; the company’s overseas sales revenue exceeded 256 million yuan, increasing by more than 56%, and its share of company revenue rose to more than 19%; as of December 31, 2025, the company had cumulatively submitted 759 patent applications and cumulatively obtained 277 authorized domestic and international patents.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes